Expression of NF-κB p65 phosphorylated at serine-536 in rectal cancer with or without preoperative radiotherapy

Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.10.1016/S0092-8674(00)81683-9Search in Google Scholar

Moynagh PN. The NF-kappaB pathway. J Cell Sci 2005; 118: 4589-92.10.1242/jcs.0257916219681Search in Google Scholar

Sun XF, Zhang H. NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases. Histol Histopathol 2007; 22: 1387-98.Search in Google Scholar

Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 1999; 274: 30353-6.10.1074/jbc.274.43.3035310521409Search in Google Scholar

Viatour P, Merville MP, Bours V, Chariot Al. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 2005; 30: 43-52.10.1016/j.tibs.2004.11.00915653325Search in Google Scholar

Miyakoshi J, Yagi K, Inhibition of IκB-α phosphorylation at serine and tyrosine acts independently on sensitization to DNA damaging agents in human glioma cells. Br J Cancer 2000; 82: 28-33.10.1054/bjoc.1999.0872236317810638962Search in Google Scholar

Yamagashi N, Miyakoshi J, Takebe H. Enhanced radiosensitivity by inhibition of nuclear factor kappa B activation in human malignant glioma cells. Int J Radiat Biol 1997; 72: 157-62.10.1080/0955300971433749269308Search in Google Scholar

Velenik V, Oblak I; Anderluh F. Quality of life in patients after combined modality treatment of rectal cancer: Report of a prospective phase II study. Radiol Oncol 2008; 42: 207-14.10.2478/v10019-008-0019-zSearch in Google Scholar

Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. New Eng J Med 1997; 336: 980-7.10.1056/NEJM1997040333614029091798Search in Google Scholar

Velenik V. Locally recurrent rectal cancer: treatment options. Radiol Oncol 2009; 43: 144-51.10.2478/v10019-009-0028-6Search in Google Scholar

Loftås P, Önnesjö S, Widegren E, Adell G, Kayed H, Kleeff J, et al. Expression of FXYD-3 is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy. Int J Radiat Oncol Biol Phys 2009; 75: 137-42.10.1016/j.ijrobp.2008.10.07619289258Search in Google Scholar

Pfeifer D, Gao J, Adell G, Sun X-F. Expression of the p73 protein in rectal cancers with or without preoperative radiotherapy. Int J Radiat Oncol Biol Phys 2006; 65: 1143-8.10.1016/j.ijrobp.2006.02.02816750334Search in Google Scholar

Wallin Å, Svanvik J, Adell G, Sun X-F. Expression of PRL proteins at invasive margin of rectal cancers in relation to preoperative radiotherapy. Int J Radiat Oncol Biol Phys 2006; 65: 452-8.10.1016/j.ijrobp.2005.12.04316626893Search in Google Scholar

Zhang ZY, Zhao ZR, Adell G, Jarlstelt I, Cul YX, Kayed H, et al. MAC30 in rectal cancers with or without preoperative radiotherapy. Oncology 2006; 71: 259-65.10.1159/00010644917657172Search in Google Scholar

Lind DS, Hochwald SN, Malaty J, Rekkas S, Hebig P, Mishra G, et al. Nuclear factor-κB is upregulated in colorectal cancer. Surgery 2001; 130: 363-9.10.1067/msy.2001.11667211490372Search in Google Scholar

Yu HG, Yu LL, Yang Y, LuoH-S, Yu J-P, MeierJJ, et al. Increased expression of RelA/nuclear factor-kappa B protein correlates with colorectal tumorigenesis. Oncology 2003; 65: 37-45.10.1159/00007120312837981Search in Google Scholar

Christian S, Winkler R, Helfrich I, Boos AM, Besemfelder E, Schadendorf D, et al. Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells. Am J Pathol 2008; 172: 486-94.10.2353/ajpath.2008.070623231237418187565Search in Google Scholar

MacFadyen J, Savage K, Wienke D, Isacke CM. Endosialin is expressed on stromal fibroblasts and CNS pericytes in mouse embryos and is downregulated during development. Gene Expr Patterns 2007; 7: 363-69.10.1016/j.modgep.2006.07.00616965941Search in Google Scholar

Tomkowicz B, Rybinski K, Foley B, Ebel W, Kline B, Routhier E, et al. Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration. Proc Natl Acad Sci (USA) 2007; 104: 17965-70.10.1073/pnas.0705647104208428017986615Search in Google Scholar

Morrison BW, Moorman JR, Kowdley GC, Kobayashi YM, Jones LR, Leder P. Mat-8, a novel phospholemman-like protein expressed in human breast tumors, induces a chloride conductance in Xenopus oocytes. J Biol Chem 1995; 270: 2176-82.10.1074/jbc.270.5.21767836447Search in Google Scholar

Kayed H, Kleeff J, Kolb A, Ketterer K, Keleg S, Felix K, et al. FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growth. Int J Cancer 2006; 118: 43-54.10.1002/ijc.2125716003754Search in Google Scholar

Ocvirk J. Advances in the treatment of metastatic colorectal carcinoma. Radiol Oncol 2009; 43: 1-8.10.2478/v10019-009-0004-1Search in Google Scholar

Bardelli A, Saha S, Sager JA, Romans KE, Xin B, Markowitz SD, et al. PRL-3 expression in metastatic cancers. Clin Cancer Res 2003;15:5607-15.Search in Google Scholar

Sager JA, Benvenuti S, Bardelli A: PRL-3: a phosphatase for metastasis? Cancer Biol Ther 2004;3:952-3.10.4161/cbt.3.10.111515467431Search in Google Scholar

Bénard J, Douc-Rasy S, Ahomadegbe JC. TP53 family members and human cancers. Hum Mutat 2003;21:182-91.10.1002/humu.1017212619104Search in Google Scholar

Sun XF. p73 overexpression is a prognostic factor in patients with colorectal adenocarcinoma. Clin Cancer Res. 2002;8:165-70.Search in Google Scholar

Malhotra K, Luehrsen KR, Costello LL, Raich TJ, Sim K, Foltz L, et al. Identification of differentially expressed mRNAs in human fetal liver across gestation. Nucleic Acids Res 1999;27:839-47.10.1093/nar/27.3.8391482559889281Search in Google Scholar

Murphy M, Pykett MJ, Harnish P, Zang KD, George DL. Identification and characterization of genes differentially expressed in meningiomas. Cell Growth Differ 1993;4:715-22.Search in Google Scholar

Moparthi S, Arbman G, Wallin Å, Kayed H, Kleeff J, Zentgraf H, et al. Expression of MAC30 protein is related to survival and biological variables in primary and metastatic colorectal cancers. Int J Oncol 2007;30:91-5.10.3892/ijo.30.1.91Search in Google Scholar

Kayed H, Kleeff J, Ding J, Hammer J, Giese T, Zentgraf H, et al. Expression analysis of MAC30 in human pancreatic cancer and tumors of the gastrointestinal tract. Histol Histopathol 2004;19:1021-31.Search in Google Scholar